Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Vectura Fertin Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Aurora Cannabis and Vectura Fertin Pharma, Inc. Announce Launch of Novel Luo CBD Lozenge
Details : The Luo CBD Lozenge, which has a novel dissolvable format and is easy to dose, is now available for patients on Aurora’s Canadian medical cannabis patient platform.
Product Name : Luo CBD Lozenge
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 09, 2024
Lead Product(s) : Cannabidiol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Vectura Fertin Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aurora Cannabis Launches its First Medical CBD Product in Uruguay
Details : Bidiol, the first medical cannabis oil that is wholly produced domestically. The CBD oil is available in 3% and 10% concentrations and comes in 10mL and 30mL bottles for the treatment of refractory epilepsy in children and adolescents.
Product Name : Luo CBD Lozenge
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 29, 2021
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Cannabis Oil for Pain Effectiveness
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 11, 2018
Reset All
